Coixol restored SOD to 1.7-fold of the CML group (p < 0.001 vs. CML), comparable to NALC (p = 0.48 vs. coixol) and 4-PBA (p = 0.95 vs. coixol). This evidence concerns the gene SOD1 and chronic myelogenous leukemia, BCR-ABL1 positive.